To isolate naïve CD4 + and CD8 + T cells for in vitro assays, secondary lymphoid organs (spleen, mesenteric, axillary, inguinal, brachial, cervical and lumbar lymph nodes) were collected, pooled and homogenized into single cell suspensions. T cells were enriched using Dynabeads® Untouched™ Mouse T Cells Kit (Thermo Fisher, Waltham, MA) according to the manufacturer's instructions followed by Fluorescence-Activated Cell Sorting (FACS) of naïve CD4 +, CD62L + , CD25 -, CD44and CD8 + , CD62L + , CD44 -T cells using a FACSAria II (BDBiosciences). For some experiments, naïve CD4 T cells were prepared from single cell suspensions using Magnetic-Activated Cell Sorting (MACS) and a naive CD4 + T Cell negative Isolation (Miltenyi, Bergisch Gladbach, Germany).
Sorted, naïve T cells (and in some experiments CD4 + , CD25 + Tregs) were then stained with Cell Trace Violet (Thermo Fisher) according to the manufacturer's instructions. Cells were counted on a MACSQuant (Miltenyi) and 1 x 10 5 naïve T cells (or Tregs) were then stimulated on CD3 (BDBioscience) coated flat-bottomed 96-well plates (Corning Inc., Corning, NY; 10ug/ml, coating in PBS ON) with 1ug/ml soluble CD28 (BDBiosciences) in complete medium RPMI, 100mM Hepes, 2mM Glutamax, 50uM 2-mercaptoethanol, 100U/100ug/ml Penicillin/Streptomycin, 1X Non-essential amino acids, 1mM Sodium Pyruvate (all Gibco, Thermo Fisher), 10% FCS (eurobio, Courtaboeuf, France). For T cell differentiation assays the following cytokines (all R&D Biosystems) and antibodies (all BDBiosciences) were added to the culture : T h1 : 10ng/ml IL12, 10ug/ml IL4 ; T h2 : 50ng/ml IL4, 10ug/ml IFN ; T h17 : 10ng/ml IL1b, 20ng/ml IL6, 1ng/ml TGF1, 10ug/ml IFN, 10ug/ml IL4 ; T reg : 10ng/ml TGF1, 100U/ml rhIL2, 10ug/ml IFN, 10ug/ml IL4. For kinetic experiments, viable cells (defined as Live/Dead stain negative cells; Ebioscience) were analysed for surface expression of CD69, CD25 and CD44 using flow cytometry on different time points. Proliferation was measured as Division Index using Cell Trace Violet dilution and the Proliferation analysis tool provided by FlowJo (FlowJo LLC, Ashland, OR). For differentiation experiments, cells were either cultured for 7 days or split on day 3, counted and replated at 1 x 10 5 cells per well on CD3 coated wells (for T h17 cells) or in IL2 supplemented differentiation conditions. On days 3, 5 and 7, 10ng/ml PMA, 1ug/ml Ionomycin and 1ug/ml Brefeldin A were added to T cell cultures. After 4hrs, cells were harvested, stained for viability and intracellular expression of cytokines IFN, IL13 and IL17 as well as the transcription factor Foxp3. For cytokine staining, cells were fixed in BD Cytofix/Cytoperm (BDBiosciences) while cells stained for transcription factors were fixed using the Foxp3 Fixation kit (Ebioscience).
In some experiments, the following stimuli were added to T cell cultures at the indicated concentrations: TGF1: 10ng/ml; TGF3 (Miltenyi): 10ng/ml; pan-TGF (R&D Biosystems): 
Treg suppression assay
Sorted, naïve CD45.1 wt T cells were stained with Cell Trace Violet as described above and activated with CD3/CD28-beads (1 bead/cell, ThermoFisher) in round-bottomed 96-well plates (Nunc) in the presence of different concentrations of FACS-sorted CD4 + , CD25 + CD45.2 regulatory T cells from TRIM28 -/or littermate control mice. Proliferation was assessed as the Division Index 48hrs after activation.
Flow cytometry

Ex vivo phenotyping
Lymphoid Tissue: Cells were prepared in single cell suspensions using 40um Cell Strainer and a plunger (Fisher Scientific and Terumo, Tokyo, Japan) and, if necessary, red blood cells were removed using lysis buffer (Sigma) for 2min at RT. Cells were washed using FACS buffer (PBS, 1% BSA, 2mM EDTA), stained for viability in PBS for 15min at 4°C followed by wash and FcBlock using CD16/CD32 (BDBiosciences) for 20min at 4°C. After an additional wash, antibodies against surface antigens or corresponding isotype controls were added for 30min at 4°C. If needed, incubation with secondary antibody or streptavidin conjugates were performed in the same manner. Surplus antibodies were washed away, cells were fixed (15min, 4°C) using BD Cytofix/Cytoperm, washed and resuspended in 100 -200ul PBS for analysis using flow cytometry.
In case of staining for TRIM28, cells were first fixed and permeabilised using Foxp3 fixation buffer (ebioscience), stained with primary mouse monoclonal TRIM28 (clone: 20C1) and secondary mouse IgG before cells were stained for T cell markers.
Blood: Mice were bled in the retroorbital sinus and blood was recovered in 50mM PBS/EDTA. For flow cytometric analysis, antibodies were diluted in 50mM PBS/EDTA and blood samples stained and incubated for 30min at 4°C. Samples were then washed and lysed 3 times in red blood cell lysis buffer (Sigma) before being resuspended in 200ul PBS and analysed using flow cytometry.
Western Blot
MACS sorted 5 x 10 6 naïve CD4 + T cells were stimulated in 100ul/Eppendorf tube with 10ug/ml CD3 and 1ug/ml CD28 at 37°C (water bath) for up to 30min in prewarmed RPMI.
After incubation, cells were pelleted (400 x g, 5min) at 4°C in a precooled centrifuge and resuspended in 12,5ul RIPA lysis buffer (50mM Hepes (pH 7.5), 140mM NaCl (VWR, Radnor, PA), 1mM EDTA (pH8.0), 10% glycerol (Merck, Darmstadt, Germany), 0,75% NP-40 (Euromedex, Souffelweyersheim, France), 0,25% Triton X-100 (Euromedex)) supplemented with Protease inhibitor (Roche) and Phosphatase inhibitor (ThermoFisher) for 30min on ice.
In some experiments cells were activated on a CD3-coated 96-well plate with soluble CD28 and cells were harvested up to 24hrs post-activation. Lysates were pelleted at 16.000
x g for 15min and supernatants removed, mixed with 4X sample buffer (Life Technologies) and heated at 95°C for 10min. Samples were loaded on 4-12% Bis-Tris gels (Life Technologies) and gel electrophoresis was performed at constant 100V. Transfer onto PVDF membranes (BioRad, Hercules, CA) was performed at 200V for 45min. Membranes were blocked for 1hr at RT on a see-saw rocker using blocking reagent (Roche). Primary antibodies were diluted in blocking reagent in the recommended dilutions and incubated ON at 4°C on a rocker. Membranes were washed extensively in TBS/0,05% Tween and incubated with secondary antibodies diluted in blocking buffer at recommended dilutions for 2hrs at RT.
After final wash, membranes were developed using a chemiluminescence kit (Roche) and high sensitivity films (BioRad) or a Chemidoc imaging system (Biorad).
In vivo differentiation experiments
Foxp3 priming: Naïve wt CD45.1+ or TRIM28-deficient CD45.2+, CD4 + T cells were FACS sorted as described above, stained with Cell Trace Violet, mixed in a 1 :1 ratio and 5 x 10 5 cells were injected into T-cell deficient Rag2 -/mice. Four days after injection spleens were harvested and proliferation and Foxp3 expression of transferred T cells was examined using flow cytometry as described above.
OT-II immunisation: Naïve wt or TRIM28-deficient CD4 + OT-II-GFP were isolated using a CD4 + T cell enrichment kits (Thermo Fisher) as described above, followed by FACS sorting and staining with Cell Trace Violet as described above. On day -1, 5 x 10 5 sorted naïve T cells were injected i.v. into C57Bl/6 recipient mice followed by s.c. immunisation with 50g OVA in CFA (Fisher Scientific, Pittsburgh, PA) into the left flank on day 0. Four and 8 days later, mice were euthanized and draining LN and spleen removed for analysis of OT-II proliferation (Division Index based on Cell Trace Violet dilution) and cytokine production.
To assess ex vivo cytokine production, 2 x 10 6 lymphocytes from spleen or draining LN were plated in round-bottomed 96-well plates (Corning Inc.) and stimulated with 10M OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] class II peptide (Invivogen, San Diego, CA) for 40hrs. For the last 16hrs of culture, 1g/ml Brefeldin A was added before cells were harvested, stained for viability, surface expression of T cell receptor chains V2 and V5.1/5.2 and intracellular expression of cytokines IFN, IL13 or IL17.
CFA-OVA immunisations
In some experiments, C57Bl/6 wt or TRIM28 -/mice were directly injected with CFA-OVA as described above. 7 days after immunization, draining lymph nodes were removed, homogenized, counted and 2,5 -5 x 10 5 cells were restimulated with 10uM OVA 322-339 peptide, 50ug/ml HSA or PMA/Ionomycin for 48hrs in an IL4-ELISPOT assay according to the manufacturer's instructions (BDBiosciences).
T cell transfer Colitis
Transfer colitis was performed similar as reported by Powrie et al. (5) . In brief, Naïve CD62L + , CD44 lo , CD25 -, CD4 + T cells from TRIM28 -/x RorcGFP or littermate controls or CD45.1 wt mice were isolated as described above and 5 x 10 5 cells were injected i.v. into recombination-activated-gene 2 (Rag2) deficient, male, T cell-deficient recipient mice. In some experiments, 5 x 10 4 CD25 + , CD4 + from CD45.2 + TRIM28 -/x RorcGFP or littermate controls were coinjected with naïve T cells. Mice were weighed 2-3 times per week and expansion of (RorcGFP+) CD4 + T cells was monitored in blood every two weeks after injection. Mice were euthanized after 93 days or when weight dropped below 80% of the initial body weight and colon, spleen and draining lymph nodes were removed. Colon length was measured and swiss rolls prepared for further histologic analysis as described previously (6) . Spleen and lymph nodes were homogenized into single cell suspensions, cells counted and stained for presence of (RorcGFP+), CD4 + T cells. In parallel, 2 x 10 6 Lymphocytes from both organs were restimulated with 10ng/ml PMA, 1g/ml Ionomycin and 1g/ml Brefeldin A for 4hrs ex vivo before measuring intracellular production of IFN and IL17 as described above.
Ex vivo memory T cell restimulation:
TRIM28 -/or littermate control mice were allowed to age for up to 450 days before animals were sacrificed, peripheral LN, mesenteric LN and spleen removed, homogenized and subjected to FACS sorting to purify effector memory CD4 + T cells. Sorted cells were stimulated ex vivo at 5 x 10 5 cells/ml with 10ng/ml PMA, 1g/ml ionomycin for 4hrs.
Supernatants were collected and subjected to cytometric bead array analysis using Flow Cytomix T h1 /T h2 /T h17 kit (ebioscience) according to the manufacturer's protocol.
Bone marrow chimeras:
Bone marrow was prepared from tibia and femur of TRIM28 -/-, littermate control or CD45.1 congenic mice as described previously (7) . Sex-matched, Rag2-deficient (Rag2 -/-) recipient mice were irradiated with 5Gy using an X-ray generator. Mice were allowed to rest for 6 hrs before being injected i.v. with 5 x 10 6 BM cells from TRIM28 -/-, TRIM28 ΔHP1box/and HP1/ -/or littermate control mice. In some experiments, 1x10 5 CD4 + , CD25 + Tregs from TRIM28 -/or littermate control mice were coinjected along with BM cells. In a different set of experiments, BM was depleted of T cells by FACS sorting as described above using antibodies against CD4 and CD8 and depleted BM cells and sorted CD4 and CD8 bulk T cells were injected separately into Rag2 -/recipient mice. Mice were weighed every week and after 6-8 weeks, mice were sacrificed. Thymus and secondary lymphoid organs were removed, homogenized into single cell suspension and CD4 + and CD8 + T cells phenotyped using flow cytometry as described above. For mixed CD45.1 wt/ CD45.2 TRIM28 -/-BM chimeras, naïve CD4 + and CD8 + T cells were isolated using T cell enrichment and FACS sorting before being activated/differentiated in vitro into regulatory and effector T cell subsets as described above.
Seahorse assay:
Sorted, naïve CD4 + and CD8 + T cells were activated in vitro using plate-bound CD3 and soluble CD28 for 24hrs as described above. Activated T cells were harvested, counted and washed and resuspended in assay medium (Seahorse Biosciences, North Billerica, MA).
Assay plates (Seahorse Biosciences) were coated with Cell-Tak (Corning Inc.) at 22,4ug/ml in PBS for 1 hr before cells were plated at a density of 2 x 10 5 cells per well according to the manufacturer's instructions. Mitochondrial respiration and glycolysis were measured using Cell Mito Stress Kit and Glycolysis Stress Kit (both Seahorse Biosciences) according to the manufcaturer's instructions. Oligomycin was used at 2g/ml, FCCP at 1g/ml, and Antimycin/Rotenone at 1g/ml. Glycolytic flux was calculated as the difference in extracellular acidification rate (ECAR) between glucose stimulated and baseline levels. Mitochondrial respiration was defined as the difference in oxygen consumption rate (OCR) levels of oligomycin-stimulated and baseline values.
C13-glucose metabolic flux assay
Sample preparation
Sorted naïve CD4 T cells were seeded on anti-CD3-coated 48 plates (5.105 cells per well) or uncoated plates, in complete T cell medium prepared in glucose-free RPMI (Gibco), supplemented with 11mM D-glucose (Gibco, C12) or 11mM C13-glucose (Eurisotop, U-13C6 99%13C), with anti-CD28 only in stimulating conditions. 24h post-seeding, cells were resuspended, washed twice in cold PBS, and dry pellets snap-frozen in liquid nitrogen, and stored at -80ºC until analysis. Samples were then spiked in 200 µl of methanol, split into two: the first aliquot was evaporated and spiked in 50 µl water/acetonitrile (1/1) for LCMS analysis, the second was evaporated and derivatized for GCMS analysis (Izzo et al. Cell Cycle.
2017).
Labelling experiment by targeted analysis of sugar phosphates by ion pairing ultra-highperformance liquid chromatography (UHPLC) coupled to a Triple Quadrupole (QQQ) mass spectrometer.
Targeted analysis was performed on a RRLC 1260 system (Agilent Technologies, Waldbronn, Germany) coupled to a Triple Quadrupole 6410 (Agilent Technologies) equipped with an electrospray source operating in negative mode. The gas temperature was set to 325°C with a gas flow of 12 L/min. The capillary voltage was set to 4.5 kV.
10 μL of sample were injected on a Column Poroshell 120 phenyl-hexyl (100 mm x 2.1 mm particle size 2.7 µm) from Agilent technologies, protected by a guard column SB-C18 (5 mm × 2.1 mm particle size 1.8 μm) and heated at 40°C by a pelletier oven.
The gradient mobile phase consisted of 10 mM of tributylamine (TBA) and 10 mM of acetic acid (AA) in water (phase A) and in methanol (phase B). The flow rate was set to 0.2 mL/min, and gradient as follow: initial condition was 98% phase A and 2% phase B, maintained during 1 min. Molecules were then eluted using a gradient from 2% to 70% phase B over 10 min.
The column was washed using 95% mobile phase B for 2 minutes and equilibrated using 2% mobile phase B for 4 min. The autosampler was kept at 4°C.
The collision gas was nitrogen. The scan mode used was the MRM for biological samples with the Q1 corresponding to the molecule [M-H]-and with Q3 corresponding to an expected fragment. Peak detection and integration of the isotopomers were performed using the Agilent Mass Hunter quantitative software (B.07.01).
Labelling experiment by targeted analysis of by gas chromatography (GC) coupled to a
Triple Quadrupole (QQQ) mass spectrometer.
Targeted analysis methods were described in (8) . Briefly, derivatization of GC aliquot was carried out with 50µl of O-ethylhydroxylamine hydrochloride stored at room temperature in the dark for 16 hours followed by silylation with 80µl of N-tert-butyldimethylsilyl-Nmethyltrifluoroacetamid (MSTBFA) at 40°C for 30 minutes.
The GC-MS/MS method was performed on a 7890B gas chromatography coupled to a triple quadrupole 7000C (Agilent Technologies, Waldbronn, Germany) equipped with an electronic impact source (EI) operating in positive mode.
The scan mode used was the MRM for biological samples with the Q1 corresponding to the maximally derivatized molecule and with Q3 corresponding to a typical fragment of silyl group (73 or 147). Peak detection and integration of the isotopomers were performed using the Agilent Mass Hunter quantitative software (B.07.01).
Data treatment
Integrated peaks were exported as text file to be merged and integrated with R software.
After data cleaning, outputs (pdf and table raw data formats) were released to the users with the isotopes of the molecules of interest. For analysis, C13-glucose contribution to each metabolite was calculated as described (9) .
FACS measurement of cytoplasmic calcium concentrations.
Purified naïve CD4 + or CD8 + T cells (1 × 10 6 cells) were loaded with 1 µM Fluo-4 AM and Fura
Red AM (ThermoFisher) for 15 min at 37˚C in RPMI-1640 without serum. Cells were centrifuged and resuspended in 200 µl of Ringer solution. Using a BD Accuri C6 flow cytometer (BD Biosciences) the fluorescence of Fluo-4 and Fura Red was analyzed. After 2 min of baseline recording, 10 µg/ml CD3, 1 µg/ml CD28 and 20 µg/ml streptadivin were added to the cell suspension and the Ca ++ levels were recorded for 5 min. Next, 1 µM ionomycin was added to the cell suspension to induce abrupt increase in the Ca ++ level.
Finally, the ratio Fluo-4/Fura Red and the geometric mean were calculated using FloJo V10 software (BD Biosciences).
Immunohistochemistry & Microscopy:
Immunohistochemistry of colon samples:
Swiss roll samples were fixed in 4% formaldehyde and four m thick slices were cut and embedded in paraffine for further immunohistochemical analysis. CD3 (clone 145-2C11) staining was performed at pH9 (Dako S2367) using a 1:100 dilution for one hour at RT.
Staining was revealed using an Elite ABC kit (Vector Laboratories) using di-amino-benzidine (DAB) for 10 minutes. Nuclei were stained using diluted Harris hematoxylin for one minute.
All immunostainings were performed on a LabVision Autostainer (ThermoFisherScientific).
Confocal microscopy of PKC recruitment:
Coverslips (12mm , Marienfeld GmbH, Lauda-Königshofer, Germany) were coated with 0,02% poly L-lysine (Sigma) for 30min at RT before being treatd with either PBS or 10ug/ml CD3 and 1ug/ml CD28 at 4C ON. The following day, coverslips were washed three times in PBS and prewarmed at 37C for 10min before 1.5x10 5 MACS sorted naïve CD4 + T cells were added to each coverslip and incubated at 37C for 30min. After incubation, cells were washed once in cold PBS and fixed in 4% paraformaldehyde (PFA) for 15min at RT. After another wash with PBS, remaining PFA was quenched using 10mM Glycine (Sigma) for 10min at RT. Cells were washed, permeabilised and blocked using 0,2%BSA, 0,05% Saponin (staining buffer, 30min, RT). Primary polyclonal rabbit antibody PKC (CellSignaling Technologies, 1:100) was incubated for 1hr at RT in staining buffer. Coverslips were washed three times with staining buffer and AlexaFluor 488-labeled anti-rabbit secondary antibody (Invitrogen, 1:300) for 30min at RT. After additional washes, coverslips were incubated for 10min with 1uM DAPI and 0,3 units Phalloidin (both ThermoFisher) and washed one final time in water. Coverslips were mounted onto slides (Knittelglass, Braunschweig, Germany) using 4ul Fluoromount (SouthernBiotech) and left to dry ON before being analysed using a confocal microscope.
Microscopes & Image analysis.
Z-stack image acquisition was performed with a Laser Scanning Confocal (LSM780, Zeiss) from the PICT-IBiSA @Pasteur Imaging facility at Institut Curie, equipped with 40X or 100X Plan Apo objectives (numerical apertures, 1.35) and a 1-airy unit pinhole size was used.
Images were analysed on Fiji software(10) by using a set of scripts generated for automated analysis. Cells were first detected using an automatic threshold ("Triangle" method) and stacks of aligned cells were generated. Stacks were then resliced and x-projected (summing method) in order to get a "side-view" of each cell. For each experimental condition, single cell images were normalized in size and mean fluorescence intensity (MFI) and stacked. Cell by cell analysis of PKC enrichment at the immune synapse was performed by measuring MFI at the synapse normalized by the MFI in total cell and a cell by cell fold increase was obtained by normalizing each condition by respective mean enrichment in poly-L-lysine controls. "Mean cells" were generated by normalizing stacks of resliced images in MFI and size between all experimental conditions giving stacks of cells with similar MFI and identical sizes. Stacks were projected (averaging method) for each condition in order to obtain "mean cells". Mean intensity profiling of mean cells was performed by resizing them to 1-pixel height stacks. Mean fluorescence intensities were then measured for each pixel along mean cells width.
RNA isolation and analysis by qPCR or Nanonstring nCounter:
RNA was isolated from naïve, activated or differentiated effector or regulatory cells using the miRNEasy isolation kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
qPCR:
For qPCR, 200ng RNA were transcribed into cDNA using reverse transcriptase (Thermo Fisher) according to the manufacturer's instructions. qPCR was performed using 5ng of template cDNA, H 2 0, SybrGreen (Roche, Basel, Switzerland) and specific primers on a LightCycler480 (Roche) (45 cycles, 60°C annealing temperature). The following primer sequences were used (1) (11, 12) .
Nanostring nCounter:
We focused on a cohort of T-reg signature genes and counted their transcripts using NanoString assay. Total RNA (50ng) was assayed according to the manufacturer's instructions. Data were normalised using 6 housekeeping genes. Probe sets for each gene were designed and synthesized by NanoString nCounter™ technologies.
Chromatin immunoprecipitation:
Cells were crosslinked with 1% formaldehyde for 8 min, quenched with 125mM glycine, washed trice with ice-cold PBS and incubated for 10min in RIPA lysis buffer (see above). 
Transduction and protein overexpression in CD4 T cells
Myr-Akt overexpression:
Plasmids pBSFI-myr-akt1 was a gift from Peter Vogt (Addgene plasmid # 49186) and MIGR1 was a gift from Warren Pear (Addgene plasmid # 27490). pCL-Eco2 was a kindly provided by Anna-Maria Lennon-Dumenil.
Generation of Myr-Akt1-Migr1
Sequence for myristoylated Akt was amplified from pBSFI-myr-akt1 using oligos C1 and C2 (see table 1) and subcloned into MigR1 vector using EcoRI and BgiII digestion sites. After ligation, resistant colonies were amplified and sequenced using oligos S1 and S2. well. At that point, cytokines to induce Th1, Th2 or Th17 differentiation were added as described above. For glucose titration experiments, cytokines were added in glucose free medium. Cytokine production was measured 2 days after transduction.
NRP1 overexpression:
Cell line and cell culture:
The B029 T cell hybridoma recognize the IA-d restricted OVA323-339 peptide and was described in a previous publication (14) . Cells we maintained in RPMI-Ggutamax (Gibco)
supplemented with 5% FBS, 100U/ml penicillin, 100g/ml streptomycin and 10mM HEPES (pH 7.4). Cells were passaged every other day and maintained a density less than 5X10 5 cells/ml.
Lentivirus design
Nrp1 (NM_008737.1) was subcloned by PCR from a plasmid obtained from Sinobiologicals format and kept at -80 0 C until used.
Lentiviral transduction
B097 cells we transduced by adding 250 of lentiviral supernant to 750 l containing 1X10 5 in 24-well suspension cell plates. 4μg/mL of polybrene was added (Sigma-Aldrich) and cells we incubated overnight in normal culture conditions. The following day, cells were washed twice in warm culture medium and plated at a density of 1X10 5 cells/ml, and maintained at a density of less than 5X10 5 cells/ml. 3 days following transduction cells were monitored for transduction efficiency and assayed for cell proliferation.
Cell proliferation assay.
B097 cells were treated with 5mM hydroxyurea (HU) overnight in order to synchronize cell division. The next day, cells were stained with 3M CFSE diluted in PBS containing 5% FBS and incubated for 20 minutes at room temperature. Following incubation, cells were washed in cold PBS containing 5% FBS and then incubated 37degC for 15 minutes in order to promote esterase cleavage. Following incubation, cells were cultured in normal conditions, and monitored for cell division over the course of the next 96 hours by flow cytometry.
CRISPR/Cas9 deletion in naïve CD4 T cells
Nucleofection
As described in (15) , isolated naïve T cells were incubated for 24h with IL7 (5ng/mL), at a density of 5.10 6 /mL. sgRNA/Cas9 (Integrated DNA technologies) complexes were prepared following manufacturer's instructions, and cells were nucleofected using the P4-primary cells nucleofection kit (Lonza) and program DN110 in a 4D nucleofection system (Lonza). Cells were incubated for 3 days at 32ºC to increase recombination efficiency, and seeded in T cell activation and Th differentiation conditions as described above.
TIDE analysis
Genomic DNA from mock and crispr-targeted T cells was extracted using the Qiagen blood and tissue kit according to manufacturer's instructions. 200ng of DNA were used for PCR amplification using Phusion polymerase (ThermoScientific) and the following primers (Snai3_F : CCAGACCTGCACAGAGAGGA , Snai3-R : GGTGGTGCGCTATGCTAATG). PCR product was cleaned up using ampure xp beads, with a ratio of 1 (DNA) to 1.8 (beads) according to manufacturer's instructions. Enriched PCR product was sequenced using Eurofins Genomics sanger sequencing service. TIDE analysis was performed on https://tide.deskgen.com/.
Bioinformatic analysis:
Affymetrix:
Differential Analysis
Microarray data analysis was performed with R (version 3.1.0). Raw CEL files were used and the quality control step was performed with ArrayQualityMetrics package (16) . Raw data were transformed using the RMA method (Robust Multi-array Average) available in the oligo package (17) . Genes with low expression were removed of analysis if the intensity value was less than 40 using the expFilter function in EMA package (18) . Finally, the intensity values in log2 scale have been used for the rest of analysis. The differential analysis was perfomed with the limma package(19) and a gene was considered as differentially expressed if its adjusted p-value (the method of Benjamini-Hochberg was used) was lower than 0.01.
Pathway Analysis
Pathway analysis of differentially expressed genes was applied with ClueGO (version 2.1.0), Cytoscape application (version 3.1.0) (20) . The REACTOME Pathways (21) and WikiPathways (version 26.02.2014) (22) were used to perform analysis. We analyzed separately upregulated and down-regulated genes. In ClueGO options, the network type was selected as a "global network" with a minimum of 4 genes and a minimum of 5% of genes contained in cluster and a kappa score threshold of 0.3 was used. The statistical tests were performed as enrichment/depletion based on two-sided hypergeometric test with a Benjamini-Hochberg as correction method. We chose to select only pathways which adjusted p-value was lower than 0.05. Finally, all the significant pathways were regrouped in 7 major categories:
Metabolism, Cell Cycle, Immune System, Gene Expression, DNA Repair / DNA Replication, Signal Transduction and Other.
Gene Set Enrichment Analysis
Gene Set Enrichment Analysis (GSEA) (23, 24) was performed with the Treg Signature described in (25) . GSEA was running with default parameters except the number of permutation (n = 10000).
Heatmap Representation
Gene-E software (www.broadinstitute.org/cancer/software/GENE-E) was used to generate heat maps using the default parameters and one minus correlation as metric distance was applied for hierarchical clustering.
ChIP-Seq :
Reanalysis of TRIM28 ChIP-Seq:
Raw data have been downloaded from GEO database from NCBI under accession number GSE38579 (26) . Raw reads in FastQ format were mapped to the mouse reference (mm10) using Bowtie2 v2.2.5 allowing 0 mismatch and using -L 32-M 10000 parameters. Peak calling step was performed using SICER (v1.1) software (27) using 0.80 as effective genome fraction and with 500 bp, 1500 bp and 150bp for window size and gap size and frangment size, respectively. FDR threshold has been fixed at 5x10 -2 .
Pre-processing and pipeline
All DNA Samples were aligned against the mouse GRCm38/mm10 (Dec, 2011) genome using Bowtie2 (28) . The pipeline PASHA was then used to process the dataset (29) . In order to accurately represent and further process the ChIP-seq and input control signals, the Watson and Crick strand tags need to be merged after elongation/size extension to purified fragment size. The optimal elongation size of each ChIP-seq experiment was estimated in silico by employing a step-wise 10bp chromosomal sequence tag shifting and score multiplication for single-ended sequenced samples. Tag coordinates were subsequently elongated according to this estimated DNA 25 fragment size, corresponding to the tag shift maximizing the score. The fragments were extended from the 5' to the 3' ends for the paired ended sequenced samples. Then, a nucleotide score representing the genome-wide overlap of elongated tags was computed across both strands. Wiggle files for genome-wide scores were generated following a binning step, calculating the average score every 50bp.
ChIP-Seq artefact removal, normalization and input subtraction
Due to the size of the genome and relative low frequencies of binding events, we assume that more than 90% of the obtained scores from the ChIP-seq experiments represent a background (BG) level. We therefore used the genome-wide average score in each experiment to estimate the BG level. Using these average scores, it is possible to rescale the scores accordingly, acting as normalization and reducing the inter-experiment differences due to effects of different sequencing depths and/or fragment sizes.
Furthermore we employed an input subtraction step for each experiment using the normalized file for the input control. This not only allows for correction of overrepresentations of certain genomic regions due to possible (un-) favorable events during sonication and/or DNA sequencing, but also serves to reduce the signal/noise ratio especially for experiments with low enrichment values.
Average binding profiles and model gene selection
To generate average binding profiles, mm10 Refseq genes annotations were used to extract values from wiggle files associated with selected genes/regions. Gene regions exhibiting a 300bp gene-free region around the boundaries were selected, excluding all genes in the vicinity of other mRNAs to avoid ambiguities in data interpretation and to analyze a stringent set of promoters. This selection resulted in a set of 16055 murine promoters. R scripts were developed and used for retrieving bin scores inside these annotations and in a region of 4kb before and after TSSs. Based on the gene list selections, bin scores from wiggle files were used to re-center values around the TSS of all genes using linear interpolation. In total, 1000 points were interpolated for the TSS of each selected gene in all average profiles presented.
The same analysis was performed at enhancer using Differential H3K9ac ChIP-seq signal defined by Deseq(30) (comparing WT and TRIM28-KO samples pvalue < 0.05).
Enhancer identification
For the analyses shown in Fig. 6I , wiggle files of ChIP-seq signals in naïve CD4 T-cells of H3K4me1 and H3K27ac (unpublished dataset) were analyzed to extract enriched regions;
areas within 1.5kb of annotated TSSs were excluded to identify putative enhancers (manuscript in preparation). The peak-calling was performed using an in-house script fixing a threshold based on the peak height and the gap between 2 adjacent signals (31) . Regions showing a combined enrichment of H3K4me 1 and H3K27ac signals were identified as regions of interest to build a set of 13478 putative enhancers.
Statistical analysis :
Student's t-test and One-way ANOVA were used for normally distributed data while Mann- 
